To successfully advocate for new MS therapies and resources to help combat MS, we need evidence to show the great impact MS has on individuals and the country. Dr Julie Campbell’s research will provide the world’s first integrated and objective set of MS-specific health economic tools to assist building the strong economic cases to advocate for more resources.
Previously this group has prepared a landmark research report, the Health Economic Impact of Multiple Sclerosis in Australia in 2017 report, which analysed the cost of MS in Australia both to the individual and the general Australian population. It showed that, while the number of Australians living with MS continues to rise, the course of the disease is shifting with more people able to stay in work, and needing less care and support as a result of newer more readily available medications. The report also found that the costs for people living with more advanced MS are incredibly high, more than triple per person compared to those with milder disease. The quality of life impact for people living with severe disability is comparable to, or even greater than that reported for terminal metastatic cancer, chronic kidney disease and severe heart disease.
Therefore, to optimise the chance of getting decision-makers to back worthwhile treatments and interventions to halt the progression of disease severity, or to prevent the disease from occurring in the first place, Dr Campbell and her team will develop a suite of health economics tools that will help provide evidence which can be used to lobby for more resources and support in the MS sector. This comprehensive and integrated suite of tools will also study the costs and quality of life impacts for progressive onset MS specifically.
Updated 22 January 2020
Updated: 21 January, 2020
Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.
Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.
Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.